EZH2 exhibits elevated expression levels in HCC, which is notably linked to advanced disease stages, vascular invasion, and unfavorable prognostic outcomes10, and regulates the HOXA-AS2/miRNA-ceRNA network to enhance pro-tumorigenic signaling and suppress anti-tumor immunity by reducing CD8+ T cell infiltration10. The gene discussed is EZH2; the disease is hepatocellular carcinoma.